{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:48:47Z","timestamp":1790704127907,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.blre.2020.100743","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T22:02:38Z","timestamp":1597701758000},"page":"100743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["The looming storm: Blood and cytokines in COVID-19"],"prefix":"10.1016","volume":"46","author":[{"given":"Supreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarsan","family":"Kollimuttathuillam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha Manje","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maroules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2020.100743_bb0005","author":"Max Roser"},{"key":"10.1016\/j.blre.2020.100743_bb0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058","article-title":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020","volume":"25","author":"Riou","year":"2020","journal-title":"Eurosurveillance."},{"key":"10.1016\/j.blre.2020.100743_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/resp.13196","article-title":"MERS, SARS and other coronaviruses as causes of pneumonia","volume":"23","author":"Yin","year":"2018","journal-title":"Respirology."},{"key":"10.1016\/j.blre.2020.100743_bb0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.blre.2020.100743_bb0030","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100743_bb0035","author":"Organization WH"},{"key":"10.1016\/j.blre.2020.100743_bb0040","series-title":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)","year":"2020"},{"key":"10.1016\/j.blre.2020.100743_bb0045","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100743_bb0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.blre.2020.100743_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.blre.2020.100743_bb0060","first-page":"1","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.blre.2020.100743_bb0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama."},{"key":"10.1016\/j.blre.2020.100743_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"18","key":"10.1016\/j.blre.2020.100743_bb0075","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"W-j","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2020.100743_bb0080","article-title":"Hematologic parameters in patients with COVID-19 infection","author":"Fan","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2020.100743_bb0085","first-page":"1","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.blre.2020.100743_bb0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2020.100743_bb0095","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100743_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis","author":"Lagunas-Rangel","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.blre.2020.100743_bb0105","doi-asserted-by":"crossref","unstructured":"Qu R, Ling Y, Zhang YH, Wei Ly, Chen X, Li X, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19. J. Med. Virol. 2020. 2020;https:\/\/doi.org\/10.1002\/jmv.25767.","DOI":"10.1002\/jmv.25767"},{"key":"10.1016\/j.blre.2020.100743_bb0110","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.blre.2020.100743_bb0115","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;e200994. doi:https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"10.1016\/j.blre.2020.100743_bb0120","doi-asserted-by":"crossref","unstructured":"Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020. doi: https:\/\/doi.org\/10.1016\/S2352-3026(20)30109-5.","DOI":"10.1016\/S2352-3026(20)30109-5"},{"key":"10.1016\/j.blre.2020.100743_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.blre.2020.100743_bb0130","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.blre.2020.100743_bb0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.blre.2020.100743_bb0145","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Hemost"},{"issue":"5","key":"10.1016\/j.blre.2020.100743_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2020.100743_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.blre.2020.100743_bb0160","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Hemost."},{"key":"10.1016\/j.blre.2020.100743_bb0165","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.blre.2020.100743_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2020.100743_bb0175","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","author":"Cui","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2020.100743_bb0180","doi-asserted-by":"crossref","unstructured":"Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MC, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. 2020. J Thromb Haemost. 2020. doi: https:\/\/doi.org\/10.1111\/jth.14888.","DOI":"10.20944\/preprints202004.0345.v1"},{"issue":"6","key":"10.1016\/j.blre.2020.100743_bb0185","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.blre.2020.100743_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2020.100743_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","article-title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels","volume":"192","author":"Demelo-Rodr\u00edguez","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2020.100743_bb0200","doi-asserted-by":"crossref","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series","author":"Lax","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2020.100743_bb0205","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with Covid-19 \u2014 a case series","author":"Bangalore","year":"2020","journal-title":"N Eng JMed"},{"issue":"8","key":"10.1016\/j.blre.2020.100743_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160955","article-title":"D-dimer levels predict myocardial injury in ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study","volume":"11","author":"Choi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2020.100743_bb0215","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","author":"Helms","year":"2020","journal-title":"N Eng J Med."},{"key":"10.1016\/j.blre.2020.100743_bb0220","first-page":"E006","article-title":"Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua xue ye xue za zhi= Zhonghua xueyexue zazhi"},{"key":"10.1016\/j.blre.2020.100743_bb0225","doi-asserted-by":"crossref","unstructured":"Helms J, Charles Tacquard, et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a Multicenter prospective cohort study. Intensive Care Med DOI: https:\/\/doi.org\/10.1007\/s00134-020-06062-x.","DOI":"10.1007\/s00134-020-06062-x"},{"key":"10.1016\/j.blre.2020.100743_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin Immunol"},{"issue":"10234","key":"10.1016\/j.blre.2020.100743_bb0235","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.blre.2020.100743_bb0240","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.blre.2020.100743_bb0245","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2020.100743_bb0250","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1160\/TH16-08-0620","article-title":"More than an anticoagulant: do heparins have direct anti-inflammatory effects?","volume":"117","author":"Poterucha","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2020.100743_bb0255","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.blre.2020.100743_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2020.05.001","article-title":"Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19","author":"Paranjpe","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.blre.2020.100743_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16927","article-title":"Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID-19","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol."},{"issue":"6","key":"10.1016\/j.blre.2020.100743_bb0270","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2020.100743_bb0275","article-title":"Clinical observations of low molecular weight heparin in relieving inflammation in COVID-19 patients: a retrospective cohort study","author":"Shi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.blre.2020.100743_bb0280","doi-asserted-by":"crossref","unstructured":"Mycroft-West C, Su D, Elli S, Guimond S, Miller G, Turnbull J, et al. The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding. bioRxiv. 2020. doi:https:\/\/doi.org\/10.1101\/2020.03.28.20046144.","DOI":"10.1101\/2020.02.29.971093"},{"issue":"6","key":"10.1016\/j.blre.2020.100743_bb0285","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for Thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.blre.2020.100743_bb0290","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.blre.2020.100743_bb0295","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"23","key":"10.1016\/j.blre.2020.100743_bb0300","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.blre.2020.100743_bb0305","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00281-017-0640-2","article-title":"Cytokine storms in infectious diseases","volume":"39","author":"Teijaro","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.blre.2020.100743_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.blre.2020.100743_bb0315","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","article-title":"Analysis of serum cytokines in patients with severe acute respiratory syndrome","volume":"72","author":"Zhang","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.blre.2020.100743_bb0320","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza a (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"De Jong","year":"2006","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.blre.2020.100743_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000604","article-title":"Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes","volume":"5","author":"Cill\u00f3niz","year":"2009","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.blre.2020.100743_bb0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/mi.2017.71","article-title":"Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense","volume":"11","author":"Leiva-Ju\u00e1rez","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"8","key":"10.1016\/j.blre.2020.100743_bb0335","doi-asserted-by":"crossref","first-page":"L731","DOI":"10.1152\/ajplung.00309.2014","article-title":"Pulmonary epithelial barrier function: some new players and mechanisms","volume":"308","author":"Brune","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.blre.2020.100743_bb0340","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.blre.2020.100743_bb0345","doi-asserted-by":"crossref","unstructured":"Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol doi:https:\/\/doi.org\/10.1002\/jmv.25770.","DOI":"10.1002\/jmv.25770"},{"key":"10.1016\/j.blre.2020.100743_bb0350","first-page":"1","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"00026","key":"10.1016\/j.blre.2020.100743_bb0355","first-page":"v1","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"202003","author":"Xu","year":"2020","journal-title":"ChinaXiv."},{"key":"10.1016\/j.blre.2020.100743_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2020.03.300","article-title":"Tocilizumab, an anti-IL6 receptor antibody, to treat COVID-19-related respiratory failure: a case report","author":"Michot","year":"2020","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.blre.2020.100743_bb0365","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.blre.2020.100743_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.blre.2020.100743_bb0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","article-title":"Clinical significance of chemokine receptor antagonists","volume":"16","author":"Miao","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.blre.2020.100743_bb0385","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.blre.2020.100743_bb0390","article-title":"Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report","author":"Horby","year":"2020","journal-title":"medRxiv"},{"issue":"18","key":"10.1016\/j.blre.2020.100743_bb0395","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2010-05-282194","article-title":"Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease","volume":"116","author":"Strouse","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.blre.2020.100743_bb0400","doi-asserted-by":"crossref","unstructured":"Nur E, Gaartman A, van Tuijn C, Tang M, Biemond B. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19). Am J Hematol 2020 Apr 8. doi: https:\/\/doi.org\/10.1002\/ajh.25821.","DOI":"10.1002\/ajh.25821"},{"key":"10.1016\/j.blre.2020.100743_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25809","article-title":"COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient","author":"Beerkens","year":"2020","journal-title":"Am J Hematol"},{"issue":"18","key":"10.1016\/j.blre.2020.100743_bb0410","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic Purpura in a patient with Covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2030093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2030093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:25:36Z","timestamp":1759436736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2030093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":79,"alternative-id":["S0268960X2030093X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2020.100743","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The looming storm: Blood and cytokines in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2020.100743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100743"}}